128 related articles for article (PubMed ID: 29303105)
21. Challenges and priorities in the management of HIV/HBV and HIV/HCV coinfection in resource-limited settings.
Easterbrook P; Sands A; Harmanci H
Semin Liver Dis; 2012 May; 32(2):147-57. PubMed ID: 22760654
[TBL] [Abstract][Full Text] [Related]
22. Management of hepatitis C patients with decompensated liver disease.
Hsu CS; Kao JH
Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):679-88. PubMed ID: 26782619
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel.
Viganò M; Perno CF; Craxì A;
Dig Liver Dis; 2017 Jul; 49(7):731-741. PubMed ID: 28456519
[TBL] [Abstract][Full Text] [Related]
24. Universal screening for chronic hepatitis C virus.
Shiffman ML
Liver Int; 2016 Jan; 36 Suppl 1():62-6. PubMed ID: 26725899
[TBL] [Abstract][Full Text] [Related]
25. Closing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 Infection.
Martin MT; Deming P
Pharmacotherapy; 2017 Jun; 37(6):735-747. PubMed ID: 28374965
[TBL] [Abstract][Full Text] [Related]
26. Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation.
García-Reyne A; Lumbreras C; Fernández I; Colina F; Abradelo M; Magan P; San-Juan R; Manrique A; López-Medrano F; Fuertes A; Lizasoain M; Moreno E; Aguado JM
Transpl Infect Dis; 2013 Aug; 15(4):405-15. PubMed ID: 23725370
[TBL] [Abstract][Full Text] [Related]
27. American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection.
Jacobson IM; Lim JK; Fried MW
Gastroenterology; 2017 May; 152(6):1578-1587. PubMed ID: 28344022
[TBL] [Abstract][Full Text] [Related]
28. [Hepatitis C virus genotype 3: that simple, yet that complex (corrected)].
Batskikh SN; Morozov SV; Chulanov VP; Pokrovsky VI
Ter Arkh; 2012; 84(11):4-10. PubMed ID: 23252240
[TBL] [Abstract][Full Text] [Related]
29. Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office.
; Yee HS; Currie SL; Darling JM; Wright TL
Am J Gastroenterol; 2006 Oct; 101(10):2360-78. PubMed ID: 17032203
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C in pregnancy: screening, treatment, and management.
; Hughes BL; Page CM; Kuller JA
Am J Obstet Gynecol; 2017 Nov; 217(5):B2-B12. PubMed ID: 28782502
[TBL] [Abstract][Full Text] [Related]
31. Advances in the treatment of hepatitis C.
Lawrence SP
Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
[TBL] [Abstract][Full Text] [Related]
32. Successful and Safe Long-Term Standard Antiviral Therapy in a Patient with "Explosive" Immune Response in Course of HCV-Related Liver Cirrhosis.
Conca P; Cafaro G; De Renzo A; Coppola A; Cimino E; Tarantino G
Int J Mol Sci; 2015 Jun; 16(6):14075-85. PubMed ID: 26101866
[TBL] [Abstract][Full Text] [Related]
33. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
[TBL] [Abstract][Full Text] [Related]
34. Outcome and management of hepatitis C in liver transplant recipients.
Chan SE; Rosen HR
Clin Infect Dis; 2003 Sep; 37(6):807-12. PubMed ID: 12955642
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus and liver transplantation: where do we stand?
Burra P; De Martin E; Zanetto A; Senzolo M; Russo FP; Zanus G; Fagiuoli S
Transpl Int; 2016 Feb; 29(2):135-52. PubMed ID: 26199060
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus risk factors in the Turkish community.
Yildirim B; Tahan V; Ozaras R; Aytekin H; Mert A; Tabak F; Senturk H
Dig Dis Sci; 2005 Dec; 50(12):2352-5. PubMed ID: 16416188
[TBL] [Abstract][Full Text] [Related]
37. Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation.
Dumortier J; Leroy V; Duvoux C; de Ledinghen V; Francoz C; Houssel-Debry P; Radenne S; d'Alteroche L; Fougerou-Leurent C; Canva V; di Martino V; Conti F; Kamar N; Moreno C; Lebray P; Tran A; Besch C; Diallo A; Rohel A; Rossignol E; Abergel A; Botta-Fridlund D; Coilly A; Samuel D; Duclos-Vallée JC; Pageaux GP
Liver Transpl; 2016 Oct; 22(10):1367-78. PubMed ID: 27348086
[TBL] [Abstract][Full Text] [Related]
38. [Current Guidelines for treatment of hepatitis C. The eradication of HCV as a goal].
Sarrazin C; Zeuzem S
Pharm Unserer Zeit; 2011 Jan; 40(1):52-9. PubMed ID: 21194083
[No Abstract] [Full Text] [Related]
39. MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis.
Gelley F; Zadori G; Nemes B; Fassan M; Lendvai G; Sarvary E; Doros A; Gerlei Z; Nagy P; Schaff Z; Kiss A
J Gastroenterol Hepatol; 2014 Jan; 29(1):121-7. PubMed ID: 24033414
[TBL] [Abstract][Full Text] [Related]
40. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
